Geneos Wealth Management’s DXC Technology DXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.8K | Sell |
1,015
-4
| -0.4% | -$54 | ﹤0.01% | 1919 |
|
|
2025
Q4 | $14.9K | Buy |
1,019
+4
| +0.4% | +$55 | ﹤0.01% | 1835 |
|
|
2025
Q3 | $13.8K | Sell |
1,015
-278
| -22% | -$3.95K | ﹤0.01% | 1854 |
|
|
2025
Q2 | $19.8K | Sell |
1,293
-1,036
| -44% | -$15.9K | ﹤0.01% | 2035 |
|
|
2025
Q1 | $39.7K | Buy |
2,329
+1,523
| +189% | +$29.6K | ﹤0.01% | 2028 |
|
|
2024
Q4 | $16.1K | Sell |
806
-117
| -13% | -$2.47K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $19.1K | Buy |
923
+68
| +8% | +$1.35K | ﹤0.01% | 1576 |
|
|
2024
Q2 | $16.3K | Sell |
855
-1
| -0.1% | -$19 | ﹤0.01% | 1402 |
|
|
2024
Q1 | $18.2K | Sell |
856
-2
| -0.2% | -$44 | ﹤0.01% | 1388 |
|
|
2023
Q4 | $19.6K | Sell |
858
-31
| -3% | -$690 | ﹤0.01% | 1359 |
|
|
2023
Q3 | $18.5K | Hold |
889
| – | – | ﹤0.01% | 1397 |
|
|
2023
Q2 | $23.8K | Buy |
889
+33
| +4% | +$822 | ﹤0.01% | 1317 |
|
|
2023
Q1 | $21.9K | Sell |
856
-33
| -4% | -$899 | ﹤0.01% | 1318 |
|
|
2022
Q4 | $23.6K | Hold |
889
| – | – | ﹤0.01% | 1281 |
|
|
2022
Q3 | $21K | Sell |
889
-339
| -28% | -$9.32K | ﹤0.01% | 1304 |
|
|
2022
Q2 | $36K | Buy |
1,228
+265
| +28% | +$8.22K | ﹤0.01% | 1417 |
|
|
2022
Q1 | $31K | Sell |
963
-537
| -36% | -$17.8K | ﹤0.01% | 1583 |
|
|
2021
Q4 | $48K | Buy |
1,500
+257
| +21% | +$8.37K | ﹤0.01% | 1497 |
|
|
2021
Q3 | $43K | Sell |
1,243
-184
| -13% | -$6.96K | ﹤0.01% | 1558 |
|
|
2021
Q2 | $57K | Sell |
1,427
-173
| -11% | -$6.17K | ﹤0.01% | 1408 |
|
|
2021
Q1 | $52K | Hold |
1,600
| – | – | ﹤0.01% | 1609 |
|
|
2020
Q4 | $41K | Buy |
1,600
+80
| +5% | +$1.71K | ﹤0.01% | 1552 |
|
|
2020
Q3 | $24K | Sell |
1,520
-76
| -5% | -$1.39K | ﹤0.01% | 1568 |
|
|
2020
Q2 | $24K | Sell |
1,596
-8
| -0.5% | -$127 | ﹤0.01% | 1537 |
|
|
2020
Q1 | $22K | Sell |
1,604
-12
| -0.7% | -$317 | ﹤0.01% | 1467 |
|
|
2019
Q4 | $59K | Sell |
1,616
-731
| -31% | -$23.8K | ﹤0.01% | 1169 |
|
|
2019
Q3 | $69K | Sell |
2,347
-162
| -6% | -$6.9K | ﹤0.01% | 1030 |
|
|
2019
Q2 | $138K | Sell |
2,509
-12
| -0.5% | -$694 | 0.01% | 793 |
|
|
2019
Q1 | $162K | Sell |
2,521
-53
| -2% | -$3.39K | 0.01% | 717 |
|
|
2018
Q4 | $136K | Buy |
2,574
+893
| +53% | +$61.7K | 0.01% | 734 |
|
|
2018
Q3 | $157K | Sell |
1,681
-1,037
| -38% | -$91.8K | 0.01% | 729 |
|
|
2018
Q2 | $219K | Sell |
2,718
-501
| -16% | -$43.1K | 0.02% | 547 |
|
|
2018
Q1 | $280K | Buy |
3,219
+13
| +0.4% | +$1.14K | 0.02% | 441 |
|
|
2017
Q4 | $263K | Sell |
3,206
-69
| -2% | -$5.57K | 0.02% | 459 |
|
|
2017
Q3 | $243K | Buy |
3,275
+37
| +1% | +$2.63K | 0.02% | 460 |
|
|
2017
Q2 | $214K | Buy |
+3,238
| New | +$215K | 0.02% | 481 |
|
Other funds holding DXC
VPM
GCM
VCM
Geneos Wealth Management's DXC Position: Q1 2026 in Review
Geneos Wealth Management reduced its DXC Technology (DXC) stake by 0.39% in Q1 2026, selling an estimated $54 and leaving 1,015 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.
Geneos Wealth Management first reported a position in DXC in Q2 2017 and has held it in 36 quarters since. The position peaked at $280K in Q1 2018. 438 funds tracked by Wall St. Rank hold DXC as of Q1 2026.
- Geneos Wealth Management held 1,015 shares of DXC Technology worth $12.8K as of Q1 2026.
- Geneos Wealth Management sold 4 DXC Technology shares in Q1 2026, an estimated $54.
- DXC Technology made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1919 holding.
- Geneos Wealth Management first reported a position in DXC Technology in Q2 2017 and has held it in 36 quarters since.
- Geneos Wealth Management's DXC Technology position peaked at $280K in Q1 2018.
- 438 funds tracked by Wall St. Rank held DXC Technology as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.